Newlink Genetics - fraud at its finest in the heartland

Discussion in 'Biotech Startups' started by anonymous, May 10, 2016 at 2:40 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    So, the company announces their lead platform not only didn't work but their "off the shelf" immunotherapy actually appears to have shortened survival for the pancreatic patients they treated in their pivotal phase 3 study. Why didn't they have a FUTILITY analysis? Simple .. Charles Link (CEO) and Brian Wiley (Chief Commercial) are FRAUDS. They always have been and always will be. Wiley is slime and offers no substance. They both reaped millions from a failed product platform.

    Wiley along with the Link brothers will be investigated and ultimately will wear stripes. They have known the past 24 months the study would fail from the early interim analyses! They have manipulated data, cost pancreatic cancer patients an average of 3 months of survival (more for those who really didn't benefit from their fraudulent vaccine.

    Now what? They will both burn ... but before hand, they will both be somebody's Beach in Jail. Wiley will look good in Stripes. No doubt!!! SEC / OIG go after this fraudulent BIOTECH that gives our industry a Bad reputation. ImClone v2 can now be found in Ames, Iowa with the LINK brothers and Slimy Wiley.
     

  2. anonymous

    anonymous Guest

    Both the CEO (Link) and CMO (Vahanian) were in cohoots. Amazing how these small biotech companies build unsubstantiated value, allow a few people to get filthy rich, then fail miserably prior to gaining FDA approval for a product. Cancer patients and investors lose big time ... the real criminals take their money and run to their next failed venture.

    Link and Vahanian should be investigated by the SEC, along with the other insiders who built the stock price up on false pretense and promises of an early trial readout.

    Agree with prior post - these folks should be in jail. Give the entire biotech industry a bad reputation. Greed and dishonesty should not be rewarded.
     
  3. anonymous

    anonymous Guest

    Bunch of greedy, dishonest, unethical tools at Newlink.Will be a satisfying day when all of the shareholder lawsuits and eventual SEC investigation finds wrongdoing (no doubt based upon the cast of "execs" at this fake, wannabe immunotherapy company) by the execs and not only asks for individual execs to payback gains but also requires them to do some hard time.

    Wiley, Link and Vahanian will look GREAT in stripes. Amen to that day ... couldn't be sooner.

    So sorry for the pancreatic cancer community that this company was about greed and dishonesty with no substance or true merit for their platform.